Nerve-sparing focal cryoablation of prostate cancer

Current Opinion in Urology

Volumn 19, Issue 2, 2009, Pages 182-187

  Polascik, Thomas J ^a   Mayes, Janice M ^a   Mouraviev, Vladimir ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cryoablation; Focal therapy; Hemiablation; Prostate cancer; Review

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CANCER CONTROL; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER REHABILITATION; CANCER RISK; CANCER STAGING; CARCINOGENESIS; COLOR ULTRASOUND FLOWMETRY; CRYOABLATION; GLEASON SCORE; HUMAN; INCONTINENCE; PATIENT SELECTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; REVIEW; TREATMENT OUTCOME;

CRYOSURGERY; HUMANS; MALE; PATIENT SELECTION; PROSTATE; PROSTATIC NEOPLASMS; SURGICAL PROCEDURES, MINIMALLY INVASIVE;

EID: 60049087886     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOU.0b013e328323f603     Document Type: Review

References (48)

1. Bostwick DG, Waters DJ, Parley ER, et al. Group consensus reports from the consensus conference on focal treatment of prostatic carcinoma, Celebration, Florida, February 24, 2006. Urology 2007; 70:42-44.
2. Meiers I, Waters DJ, Bostwick DG. Preoperative prediction of multifocal prostate cancer and application of focal therapy: review 2007. Urology 2007; 70:3-8.
3. Polascik TJ, Mouraviev V. Focal therapy for prostate cancer. Curr Opin Urol 2008; 18:269-274.
4. Barqawi AB, Crawford ED. The current use and future trends of focal surgical therapy in the management of localized prostate cancer. Cancer J 2007; 13:313-317.
5. Mouraviev V, Mayes JM, Sun L, et al. Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer. Cancer 2007; 110:906-910. The large study including 1184 prostatectomy specimens from patients with localized PCa demonstrated unilateral disease in almost one in five men who may be amenable to hemiablation of the prostate.
6. Polascik TJ, Mayes JM, Sun L, et al. Pathologic stage T2a and T2b prostate cancer in the recent prostate-specific antigen era: implications for unilateral ablative therapy. Prostate 2008; 68:1380-1386.
7. D'Amico AV, Moul J, Carroll PR, et al. Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era. J Clin Oncol 2003; 21:2163-2172.
8. Miller DC, Gruber SB, Hollenbeck BK, et al. Incidence of initial local therapy among men with lower-risk prostate cancer in the United States. J Natl Cancer Inst 2006; 98:1134-1141.
9. Onik G, Narayan P, Vaughan D, et al. Focal 'nerve-sparing' cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency. Urology 2002; 60:109-114.
10. Janzen NK, Han KR, Perry KT, et al. Feasibility of nerve-sparing prostate cryosurgery: applications and limitations in a canine model. J Endourol 2005; 19:520-525.
11. Bahn DK, Silverman P, Lee F Sr, et al. Focal prostate cryoablation: initial results show cancer control and potency preservation. J Endourol 2006; 20:688-692.
12. Lambert EH, Bolte K, Masson P, Katz AE. Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer. Urology 2007; 69:1117-1120.
13. Onik G, Vaughan D, Lotenfoe R, et al. 'Male lumpectomy': focal therapy for prostate cancer using cryoablation. Urology 2007; 70:16-21.
14. Mouraviev V, Polascik TJ. Avoiding surgery in prostate cancer patients with low-risk disease. Future Med Ther 2008; 5:25-36.
15. Cresswell J, Asterling S, Chaudhary M, et al. Third-generation cryotherapy for prostate cancer in the UK: a prospective study of the early outcomes in primary and recurrent disease. BJU Int 2006; 97:969-974.
16. Miller R, Cohen JJ. Prostate cryosurgery. In: Rukstalis DB, Katz AE, editors. Handbook of urologic cryoablation. Informa UK Ltd; 2007. pp. 39-46.
17. Polascik TJ, Nosnik I, Mayes JM, Mouraviev V. Short-term cancer control after primary cryosurgical ablation for clinically localized prostate cancer using third-generation cryotechnology. Urology 2007; 70:117-121.
18. Polascik TJ, Mayes JM, Mouraviev V. From whole-gland to targeted cryoablation for the treatment of unilateral or focal prostate cancer. Oncology (Williston Park) 2008; 22:900-906; discussion 906-907, 914.
19. Ahmed HU, Emberton M. Active surveillance and radical therapy in prostate cancer: can focal therapy offer the middle way? World J Urol 2008; 26:457-467.
20. Eggener SE, Scardino PT, Carroll PR, et al. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. J Urol 2007; 178:2260-2267.
21. Jones JS. Focal or subtotal therapy for early stage prostate cancer. Curr Treat Options Oncol 2007; 8:165-172.
22. Ahmed HU, Pendse D, Illing R, et al. Will focal therapy become a standard of care for men with localized prostate cancer? Nat Clin Pract Oncol 2007; 4:632-642.
23. Ellis DS, Manny TB Jr, Rewcastle JC. Focal cryosurgery followed by penile rehabilitation as primary treatment for localized prostate cancer: initial results. Urology 2007; 70:9-15.
24. Partin AW, Mangold LA, Lamm DM, et al. Contemporary update of prostate cancer staging nomograms (Partin tables) for the new millennium. Urology 2001; 58:843-848.
25. Kattan MW, Eastham JA, Stapleton AM, et al. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 1998; 90:766-771.
26. Polascik T, Mayes J, Schroeck F, et al. Patient selection for hemi-ablative focal therapy for prostate cancer: variables predictive of tumor unilaterality in 538 radical prostatectomy specimens with low-risk disease. J Endourol 2008; 22:1099.
27. Barzell WE, Melamed MR. Appropriate patient selection in the focal treatment of prostate cancer: the role of transperineal 3-dimensional pathologic mapping of the prostate - a 4-year experience. Urology 2007; 70:27-35. This is a pioneer work to introduce a new biopsy technique with detailed mapping of the spatial distribution of cancer inside the prostate for the purpose of focal-targeted therapy.
28. Onik G, Barzell W. Transperineal 3D mapping biopsy of the prostate: an essential tool in selecting patients for focal prostate cancer therapy. Urol Oncol 2008; 26:506-510.
29. Yoon GS, Wang W, Osunkoya AO, et al. Residual tumor potentially left behind after local ablation therapy in prostate adenocarcinoma. J Urol 2008; 179:2203-2206; discussion 2206. This study demonstrates what can be missed in the contralateral (untreated lobe) of the prostate after hemiablation, based on data of 100 prostatectomy specimens from patients with biopsy-proven unilateral disease and low-risk clinical features.
30. Andriole GL, Bullock TL, Belani JS, et al. Is there a better way to biopsy the prostate? Prospects for a novel transrectal systematic biopsy approach. Urology 2007; 70:22-26.
31. Boccon-Gibod LM, de Longchamps NB, Toublanc M, et al. Prostate saturation biopsy in the reevaluation of microfocal prostate cancer. J Urol 2006; 176:961 -963; discussion 963-964.
32. Graser A, Heuck A, Sommer B, et al. Per-sextant localization and staging of prostate cancer: correlation of imaging findings with whole-mount step section histopathology. AJR Am J Roentgenol 2007; 188:84-90.
33. Iczkowski KA, Hossain D, Torkko KC, et al. Preoperative prediction of unifocal, unilateral, margin-negative, and small volume prostate cancer. Urology 2008; 71:1166-1171. The authors presented a very well done clinical study with matched biopsy and prostatectomy from 393 patients at two institutions. They found that unilateral or unifocal cancer on biopsy are among the strongest predictors of unilateral, unifocal, and small-volume PCa.
34. Crawford ED, Barqawi A. Targeted focal therapy: a minimally invasive ablation technique for early prostate cancer. Oncology (Williston Park) 2007; 21:27-32; discussion 33-24, 39.
35. Mayes J, Mouraviev V, Sun L, et al. Can the conventional sextant prostate biopsy reliably diagnose unilateral prostate cancer in low-risk, localized, prostate cancer? 26th World Congress of Endourology and SWL Abstract FP12-37, pp. 333-334.
36. Barber T, Pansare V, Nikolavsky D, et al. Pathologic characteristics of contralateral prostate cancer among patients with a single positive core. J Urol 2006; 175 (suppl):507.
37. Presti JC. Prostate biopsy: current status and limitations. Rev Urol 2007; 9:93-98.
38. Ravery V, Dominique S, Panhard X, et al. The 20-core prostate biopsy protocol - a new gold standard? J Urol 2008; 179:504-507.
39. Jones JS. Saturation biopsy for detecting and characterizing prostate cancer. BJU Int 2007; 99:1340-1344.
40. Rukstalis DB, Goldknopf JL, Crowley EM, Garcia FU. Prostate cryoablation: a scientific rationale for future modifications. Urology 2002; 60:19-25.
41. Polascik T, Mayes J, Schroeck F, et al. Patient selection for hemi-ablative focal therapy of prostate cancer: variables predictive of tumor unilaterality based upon radical prostatectomy. Cancer 2009 (in press).
42. Johnstone PA, Rossi PJ, Jani AB, Master V. 'Insignificant' prostate cancer on biopsy: pathologic results from subsequent radical prostatectomy. Prostate Cancer Prostatic Dis 2007; 10:237-241.
43. Onik G, Vaughan D, Lotenfoe R, et al. The 'male lumpectomy': focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up. Urol Oncol 2008; 26:500-505.
44. ASTRO. Consensus statement. Guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 1997; 37:1035-1041.
45. Ellis D, Jones J, Pisters L, et al. Subtotal/partial gland prostate cryoablation: results of 341 patients from multiple centers tracked with the cold registry. J Urol 2008; 179:397.
46. Blana A, Murat FJ, Walter B, et al. First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer. Eur Urol 2008; 53:1194-1201.
47. Trachtenberg J, Bogaards A, Weersink RA, et al. Vascular targeted photodynamic therapy with palladium-bacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: assessment of safety and treatment response. J Urol 2007; 178:1974-1979; discussion 1979.
48. Muto S, Yoshii T, Saito K, et al. Focal therapy with high-intensity-focused ultrasound in the treatment of localized prostate cancer. Jpn J Clin Oncol 2008; 38:192-199.